National Comprehensive Cancer Network



About NCCN

Hepatobiliary Cancers Panel - Disclosures as of 5/18/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Thomas A. Abrams, MD

None

None

None

None

8/24/2012

Chandrakanth Are, MD, FRCS

None

None

None

None

5/5/2012

Al B. Benson III, MD, FACP

Abbott Laboratories;
Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
Alchemia;
gilead;
Infinity

Agendia BV;
Bayer HealthCare;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
National Cancer Institute;
Precision Therapeutics, Inc.

None

None

8/31/2012

P. Mark Bloomston, MD

None

Onyx Pharmaceuticals, Inc.

None

None

10/6/2012

Daniel T. Chang, MD

None

None

None

None

3/15/2013

Bryan M. Clary, MD

None

None

None

None

11/6/2012

Anne M. Covey, MD

None

None

None

None

8/6/2012

Steven A. Curley, MD

None

None

None

None

10/7/2011

Michael I. D'Angelica, MD

None

None

None

None

8/13/2012

William D. Ensminger, MD, PhD

Jennerex

None

None

None

9/12/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Renuka Iyer, MD

None

pathworks diagnostics

None

None

8/8/2012

R. Kate Kelley, MD

Eli Lilly and Company;
Genomic Health, Inc.;
Merck & Co., Inc.;
Regeneron Pharmaceuticals, Inc.

Exelixis Inc.;
Genomic Health, Inc.

None

None

5/9/2012

David Linehan, MD

Novartis Pharmaceuticals Corporation

None

None

None

3/5/2013

Mokenge P. Malafa, MD, FACS

None

None

None

None

9/14/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Nicole McMillian, MS

None

None

None

None

3/27/2013

Steven G. Meranze, MD

None

None

None

None

10/6/2011

James O. Park, MD

None

None

None

None

8/6/2012

James A. Posey, MD

None

None

None

None

4/16/2010

Courtney Scaife, MD

None

None

None

None

5/9/2012

Elin R. Sigurdson, MD, PhD

None

None

None

None

4/2/2012

Hema Sundar, PhD

None

None

None

None

2/25/2013

Gary A. Tian, MD, PhD

None

Eisai Inc.;
Allos;
AMAG

None

None

4/5/2012

Jean-Nicolas Vauthey, MD

None

None

None

None

9/13/2012

Alan P. Venook, MD

Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

Abbott Laboratories;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation

None

None

4/30/2012

Christopher Wolfgang, MD, PhD, FACS

None

None

None

None

9/10/2012

Yun Yen, MD, PhD, FACP

None

Bayer HealthCare;
Onyx Pharmaceuticals, Inc.

None

None

8/6/2012

Andrew X. Zhu, MD, PhD

None

Daiichi- Sankyo Co.;
Eisai Inc.;
sanofi-aventis U.S.

None

None

10/17/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved